您的位置: 首页 > 农业专利 > 详情页

Process for synthesis of a diarylpyrimidine non-nucleoside reverse transcriptase inhibitor
专利权人:
EMCURE PHARMACEUTICALS LIMITED
发明人:
GURJAR MUKUND KESHAV,MAIKAP GOLAKCHANDRA SUDARSHAN,JOSHI SHASHIKANT GANGARAM
申请号:
AP2011005715
公开号:
AP2858A
申请日:
2010.06.18
申请国别(地区):
AP
年份:
2014
代理人:
摘要:
A method for synthesis of diarylpyrimidine non-nucleoside reverse transcriptase inhibitor such as etravirine is provided Typically, etravirine is synthesized by the steps of a Condensing 2,4,6-trichlorpyrimidine with 3,5-dimethyl-4-hydroxybenzonitrile to obtain compound (V), b Condensing compound (V) with 4-aminobenzonitrile to obtain compound (VI), c Ammonolysis of compound (VI) to get compound (IV), d Halogenation of compound (IV) to get etravirine.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充